Press Release
Category Added in a WPeMatico Campaign
-
Business Wire1 week ago
Gigaphoton Excimer Laser for Advanced Packaging Installed at Japanese Company
OYAMA, Japan–(BUSINESS WIRE)–Gigaphoton Inc. (Head Office: Oyama, Tochigi; President and CEO: Tatsuo Enami), a manufacturer of lightsources for semiconductor lithography,…
Read More » -
Business Wire1 week ago
Sustainability Focus Session 2025
PERTH, Australia–(BUSINESS WIRE)–An overview of UNESCO’s World Heritage Listing of Murujuga and its significance for Woodside, including a question-and-answer session,…
Read More » -
Anchorage Digital Integrates Middleware Provider BridgePort to Enhance Institutional Settlement Infrastructure
NEW YORK and SAN FRANCISCO, Dec. 7, 2025 /PRNewswire/ — Anchorage Digital, a crypto platform that provides institutions with integrated financial…
Read More » -
Business Wire1 week ago
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination…
Read More » -
Business Wire1 week ago
Panah Master Fund Counters M&A Capital Partners’ Rebuttal to its Previously Submitted Shareholder Proposals
TOKYO–(BUSINESS WIRE)–Panah Master Fund (“the Fund”) today has published its response to the Board of Directors of M&A Capital Partners…
Read More » -
Business Wire1 week ago
National Fuel Gas Company Investigated for Breaches of Fiduciary Duty – Contact the DJS Law Group to Discuss Your Rights – NFG
LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of National Fuel Gas…
Read More » -
Business Wire1 week ago
Gartner Announces Gartner Finance Symposium/Xpo 2026 in Sydney
CFOs to Learn How AI is Reshaping Finance, from Predictive Analytics and Risk Assessment to Automation and Fraud Detection –(BUSINESS…
Read More » -
Lilly’s Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)
In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved…
Read More » -
Replicor publishes data from its compassionate access program in HBV/HDV
MONTREAL, Dec. 7, 2025 /PRNewswire/ – Replicor Inc. announced the publication of data from its first global compassionate access program…
Read More » -
Business Wire1 week ago
Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK–(BUSINESS WIRE)–Halper Sadeh…
Read More »


